← Open Payments lookup

PHILIP SANGSTER: Open Payments

NPI 1801405758 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,048 in 167 payments from 21 companies in 2025. Trend: 2023 $1,490 · 2024 $3,428 · 2025 $4,048

Food & beverage: $3,196Travel & lodging: $848Education: $5
CompanyPaymentsAmount
Brainsway USA INC1$848
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)30$458
Neurocrine BioSciences, Inc.16$324
Alkermes, Inc.12$274
Otsuka America Pharmaceutical, Inc.13$262
Lundbeck LLC12$231
Vanda Pharmaceuticals Inc.9$218
ABBVIE INC.16$195
Tris Pharma Inc9$180
Janssen Pharmaceuticals, Inc8$174

Products named: Deep Tms, CAPLYTA, INGREZZA, REXULTI, ARISTADA, ABILIFY ASIMTUFII, VRAYLAR, Dyanavel XR.

Industry payments across GA — which companies pay providers there.